Researchbreadcrumb separatorStudiesbreadcrumb separatorD:A:Dbreadcrumb separatorPresentationsbreadcrumb separator2013
Presentations 2013

14th European AIDS Conference, October 16-19, 2013, Brussels, Belgium

Oral presentation

1 Prediction of global CVD risk in HIV-positive persons. N Friis Møller, L Ryom, C Smith, R Weber, P Reiss, F Dabis, S De Wit, A D´Arminio Monforte, O Kirk, E Fontas, C Sabin, A Phillips, J Lundgren, M Law for the D:A:D Study group.

Poster presentation

1 Investigating the causal impact of PI- and NNRTI-containing cART on the risk of mortality: methodological challenges.
CJ Smith, D Ford, M Hernan, CA Sabin, P Reiss, S de Wit, A d’Arminio Monforte, C Pradier, M Law, E Fontas, R Weber, M Bruyand, W el-Sadr, A Phillips, L Ryom, JD Lundgren for the D:A:D Study Group.


20th Conference on Retroviruses and Opportunistic Infections, CROI 2013, 3-6 March 2013, Atlanta

Oral Presentation

1 Increased risk of cardiovascular disease (CVD) with age in men: a comparison of D:A:D with HIV negative CVD risk equations. K Petoumenos, W El-Sadr, A d’Arminio Monforte, C Sabin, P Reiss, L Ryom, S De Wit, M Rickenbach, JD Lundgren and MG Law for the D:A:D Study group.

Poster presentations

1 Cancer Risk and Use of PI or NNRTI-based Combination Antiretroviral Therapy (cART): The D:A:D Study. M Bruyand, L Ryom, L Shepherd, P Reiss, S de Wit, A d’Arminio Monforte, M Rickenbach, A Philips, C Pradier, M Law, W El-Sadr, J Lundgren, C Sabin for the D:A:D study group.

2 Predictors of Advanced Chronic Kidney Disease and End-Stage Renal Disease in HIV-Positive Persons in D:A:D. L Ryom, A Mocroft, O Kirk, M Ross, P Reiss, W El-Sadr, S de Wit, P Morlat, O Moranne, CA Fux, A d’Arminio Monforte, M Law and JD Lundgren for the D:A:D Study group.

3 Improvements in short-term mortality following myocardial infarction (MI): the D:A:D Study.C Sabin, L Ryom, M Law, W El-Sadr, O Kirk, M Bruyand, P Reiss, C Pradier, B Ledergerber, A d’Arminio Monforte, S de Wit, JD Lundgren on behalf of the D:A:D Study Group.